Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma
This study has been terminated.
Sponsor:
University of Pennsylvania
Collaborators:
Bristol-Myers Squibb
Roche Pharma AG
Information provided by:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00353457
First received: July 14, 2006
Last updated: September 29, 2010
Last verified: September 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |